Variant: rs80359388 

    present in Gene: BRCA2
    present in Chromosome: 13
    Position on Chromosome: 32337899
    Alleles of this Variant: TT/-;T

rs80359388 in BRCA2 gene and BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2 PMID 15131399 2004 Cancer variation associated with the position of the mutation in the BRCA2 gene.

rs80359388 in BRCA2 gene and Dysmorphic features PMID 16141007 2005 Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.

PMID 12677558 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

PMID 16825431 2007 Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.

PMID 15796958 2005 BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.

PMID 9497246 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

PMID 15197194 2004 Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

PMID 18042939 2007 Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.

PMID 21568838 2011 Fanconi anemia: at the crossroads of DNA repair.

PMID 21952622 2011 BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.

PMID 17416853 2007 Meta-analysis of BRCA1 and BRCA2 penetrance.

rs80359388 in BRCA2 gene and Hereditary Breast and Ovarian Cancer Syndrome PMID 25884701 2015 A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population.

PMID 26014432 2016 High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing.

PMID 20104584 2010 Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.

PMID 15382066 2004 Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations.

PMID 24156927 2014 Central European BRCA2 mutation carriers: birth cohort status correlates with onset of breast cancer.

PMID 15131399 2004 Cancer variation associated with the position of the mutation in the BRCA2 gene.

PMID 22430266 2012 Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.

PMID 16905680 2007 Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.

PMID 21324516 2011 Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.

rs80359388 in BRCA2 gene and Neoplastic Syndromes, Hereditary PMID 20694749 2010 Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.

PMID 21324516 2011 Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.

PMID 15382066 2004 Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations.

PMID 20104584 2010 Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.

PMID 16905680 2007 Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.

PMID 25884701 2015 A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population.

PMID 15131399 2004 Cancer variation associated with the position of the mutation in the BRCA2 gene.